FBIO
Fortress Biotech, Inc.
Next earnings Aug 12, 2026 · consensus $-0.20 EPS, $18.7M rev
Last earnings +3.1% on 2026-05-14
$3.02▲ +69.66%
over 1Y
L $1.71EODHDH $4.38
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today—
1W+1.0%
1M+12.3%
3M+4.9%
YTD-25.1%
1Y+69.7%
Hold
Conviction
Horizon
Medium (3–12mo)
Street · 8 analysts
Buy
Revenue grew 9.7% YoY.
Fortress Biotech, Inc. shows $63.3M in FY2025 revenue (+9.7% YoY), a 10.8% net margin, and 13.7% ROE.
Sources: SEC EDGAR (CIK 0001429260, latest 10-Q filed 2026-05-14) · as of 6/26/2026, 6:34:27 PM.
Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.